ARCHIVES

Blinatumomab Demonstrates High Response Rate in ALL

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Patients Prefer Silicone Over Saline Implants

November 26, 2010

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010